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liittyvien tuumorisuppressorien kemiallisten ja biologisten ominaisuuksien tutkimiseen. 
Ryhmä käyttää tätä tietoa luodakseen parempia keuhkosyöpämalleja, jotka mahdollistavat 
uusien sairauksien ehkäisyyn tähtäävien strategioiden kehityksen. (Verschuren group.) 
 
Tämän projektin tarkoituksena oli selvittää, vaihteleeko immunologisten geenien 
ilmentyminen hiirien Kras;Lkb1-geenien muutosten aikaan saamissa ei-pienisoluisen 
keuhkosyövän kasvaimissa. Kasvainsoluviljelmät olivat luotu ja viljelty 
uudelleenohjelmoituina epiteelisoluina (conditionally reprogrammed cell) perustuen 
kasvaimien solualkuperään (CC10+ ja SPC+). Projektissa vertaillut geenit olivat Interleukiini 
1β (Il-1β), Arginaasi 1 (Arg1), Interleukiini 6 (Il-6,) Cxcl5 ja Ccl2. Tarkastelimme projektia 
kolmesta eri koeasetelmasta: (1) eri kasvaimien geenien ilmentymisen vertailu, (2) 
kasvaimien ja niistä luotujen uudelleenohjelmoitujen solujen geenien ilmentymisen vertailu 
sekä (3) kasvatusliuoksen vaikutus uudelleenohjelmoitujen solujen geenien ilmentymiseen.  
 
Ensimmäisessä koeasetelmassa Il-1β, Arg1 ja Cxcl5 geenit ilmentyivät KL-CC10-
kasvaimissa enemmän verrattuna KL-SPC-kasvaimiin, kun taas Il-6 geenin ilmentyminen oli 
päinvastaista ja Ccl2 geenin ilmentymisessä ei näkynyt eroa. 
 
Toisen koeasetelman tulokset viittaavat siihen, että solulinjat ilmentävät mainittuja geenejä 
vähemmän kuin niiden vastaavat kasvaimet. Tämä oli nähtävissä erityisesti Il-1β geenin 
kohdalla. Il-1β geenin ilmeneminen solulinjoissa oli niin vähäistä, että se oli hankala todentaa 
qRT-PCR:llä. Poikkeuksia oli kuitenkin havaittavissa, KN85A-solulinja ilmensi Il-6 ja Ccl2 
geenejä suuremmissa määrin kuin vastaava kasvain.  
 
Kolmannessa koeasetelmassa selvisi, että kasvatusliuoksella ei ollut vaikutusta geenien 
ilmentymiseen ¾ solulinjassa, mutta Il-6 ja Ccl2 geenien ilmentyminen oli suurempaa KN85A 
solujen maljalla, johon oli vaihdettu stroomasoluviljelmästä eristetty kasvatusliuos. Tämä 
tulos viittaa siihen, että kasvatusliuos joka on eristetty stroomasoluviljelmästä, vaikuttaa vain 
tiettyjen solulinjojen geenien ilmentymiseen. 
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This project was carried out at the Institute for Molecular Medicine Finland (FIMM) in Emmy 
Verschuren’s research group. The group is investigating lung cancer and the main focus is 
on the chemical and biological properties of tumor suppressors related to lung cancer. They 
use this information to create better lung cancer model systems to investigate new strategies 
for disease prevention and therapeutic intervention. (Verschuren group.) 
 
The purpose of this project was to determine whether there are any differences in the 
expression of immune-related genes between murine Kras-mutant; Lkb1-loss of function 
driven non-small cell lung cancer tumors. These tumors were established ex vivo as 
epithelial conditionally reprogrammed cells (CRCs) based on their tumor cell-of origin (KL-
CC10+ and KL-SPC+). The genes which were compared in this project were Interleukin-1b 
(Il-1b,) Arginase-1 (Arg1), Interleukin-6 (Il-6), C-X-C motif chemokine 5 (Cxcl5) and C-C 
motif chemokine ligand 2 (Ccl2). We had three different experimental conditions: (1) CC10+ 
tumor versus SPC+ tumor, (2) tumor versus CRCs and (3) normal media versus conditioned 
media from stromal cell culture. 
 
In the tumor versus tumor experiment Il-1β, Arg1 and Cxcl5 gene expression was higher in 
KL-CC10+ positive tumors than in KL-SPC+ tumors while Il-6 expression had an opposite 
trend and Ccl2 showed no difference. 
 
Tumor versus CRC results indicated that CRCs have lower expression of selected genes, 
especially in Il-1β. In CRCs the expression of Il-1b was so low that it was almost not 
detectable by qRT-PCR. However, there were exceptions. KN85A-cell line which is a KL-
CC10 tumor, had higher Il-6 and Ccl2 expression in CRCs when compared to the matching 
tumor.  
 
Conditioned media had no effect on selected gene expression in 3 of 4 CRCs, but increased 
Il-6 and Ccl2 gene expression in KN85A CRCs compared to the normal media. The KN85A 
result in conditioned media experiment suggests that there may be a cell-line specific effect 
of conditioned media from stromal cells on immune-gene expression. 
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1 Introduction 
 
This project was carried out at the Institute for Molecular Medicine Finland (FIMM) in 
Emmy Verschuren’s research group. The group is investigating lung cancer and the main 
focus is on the chemical and biological properties of tumor suppressors related to lung 
cancer. They use this information to create better lung cancer model systems to 
investigate new strategies for disease prevention and therapeutic intervention. 
(Verschuren group.) 
 
The purpose of this project was to determine whether there are any differences in the 
expression of immune-related genes between murine Kras-mutant; Lkb1-loss of function 
driven non-small cell lung cancer tumors. These tumors were previously established ex 
vivo as epithelial conditionally reprogrammed cells (CRCs) based on tumor cell-of origin. 
The genes which were compared in this project were Interleukin-1b (Il-1b), Arginase 1 
(Arg1), Interleukin-6 (Il-6), C-X-C motif chemokine 5 (Cxcl5) and C-C motif chemokine 
ligand 2 (Ccl2). This project was inspired by study where there were found histotype-
specific immune gene signatures for certain subtypes of non-small cell lung cancers 
(Nagaraj et al. 2017). 
 
2 Non-small cell lung cancer 
 
The majority of the lung cancer cases (up to 85%) are non-small cell lung cancers 
(NSCLC). Non-small cell lung cancer can be divided into subtypes which are based on 
the different types of lung cancer cells and morphological features. These subtypes 
include adenocarcinoma (AC, 40%), squamous cell carcinoma (SCC, 30%) and 
adenosquamous carcinoma (ASC) which is less common than the other subtypes. 
(American cancer society 2016.) Human lung adenocarcinomas have been found to be 
more common in the distal part of the lung rather than in the proximal airways whereas 
the squamous cell carcinomas (SCC) more typically initiate from proximal airways 
(Asselin-Labat – Filby 2012: 2). 
 
There are two types of gene families which have a big role in cancer formation; 
oncogenes and tumor suppressor genes. Normally the human genome contains proto-
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oncogenes which play an essential role in the regulation of cell growth. If these genes 
mutate they can be permanently activated and, as a result, the cell growth becomes 
uncontrolled and this can lead to cancer initiation. Tumor suppressor gene products 
repair DNA, slow down cell division and guide cells to apoptosis. When these tumor 
suppressor genes do not function as intended, cell growth can also become uncontrolled. 
(American Cancer Society 2014.) 
 
In NSCLC the most commonly mutated oncogene, Kras is detected in around 25 % of 
all tumors in adenocarcinomas (de Castro Carpeño — Belda-Iniesta 2013). From 144 
analyzed samples, 19% of squamous cell carcinomas and 34% of adenocarcinomas 
were found to have an inactivating mutation of tumor suppressor gene Lkb1 (Ji 2007: 
807). Other studies showed that in about 30% of non-small cell lung cancer cases the 
tumor suppressors gene Lkb1 is inactivated, thus making it the most commonly mutated 
tumor suppressor gene in NSCLC (Mahoney et al. 2009; Koyama et al. 2016: 999). 
 
2.1 Cell-of origin 
 
Normal cells with genetic mutations can go through tumorigenic transformation, starting 
tumor initiation. These cells are referred as cell-of origin of the tumor. (Rycaj – Tang 
2015: 4003) NSCLC may originate from many different progenitor cell types, 2 of which 
will be introduced here. 
 
One of the many cell types located in bronchial epithelium are club cells (i.e. CCs, Clara 
cells or bronchiolar exocrine cells) which do not secrete mucus or have a cilium. It is 
estimated that 11-12% of all CCs are located in terminal bronchioles and these comprise 
approximately 15-44% of proliferating cells in bronchial tree. The main secretory protein 
of CCs is club cell protein 10 (CC10), also known as uteroglobin. (Rokicki – Rokicki – 
Wojtacha – Dżeljijli 2016: 26–27.) 
 
Alveolar epithelium is mainly comprised by type I and type II cells, with the majority (60%) 
constituted by type II cells. Alveolar type II (AT2) cells express surfactant protein C (SPC) 
(Mao et al. 2015:1–2). AT2 cells and CCs have potential to proliferate under different 
conditions and they could potentially acquire mutations and thus initiate tumor 
development (Lin et al. 2012: 2). 
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2.2 Mouse model 
 
The mouse genome is well characterized and correlates highly with the human genome, 
especially with respect to the genes shown to be important for cancer. The similarities in 
gene organization between human and murine are paralleled by similarities in the 
phenotypes which are engendered by homologous gene mutations. Even though 
characterization of mouse mutants obtained through mutagenesis or breeding has been 
very beneficial, an improved technology was developed using recombinant DNA 
technology. Creating transgenic breeding lines by injecting DNA into mouse oocytes has 
increased the capability to generate mice with developmental abnormalities and genetic 
diseases. (Wilson 2000: 201–203.)  Originally the transgenic approach was 
compromised by multiple or exceptional insertion of genes and so homologous 
recombination techniques were developed instead to accurately remove or replace an 
endogenous gene segment. (Murray – Maga 2005: 307, 309; Wilson 2000: 201–203.) 
The advantage from the angle of developmental genetics is the capability to use 
transgenic mice to evaluate the effects of new genes on mammalian development. 
(Wilson 2000: 201–203.) 
 
3 Background 
 
3.1 Tumor cell of origin and immune related gene expression 
 
The idea for this project stemmed from a recently published study where a histotype-
specific immune gene expression signature was found in NSCLC tumors (Nagaraj et al. 
2017). The model used in Nagaraj et. al. (2017: 673–674) study were transgenic mouse 
model with loxP-conditional oncogenic Kras mutant (G12D) and Lkb1 loss-of-function 
alleles. The mutations were knocked in after the mice were infected with adenoviruses 
that express Cre-recombinase. Mutations of lung progenitor cell (either CC10+ or SPC+ 
cells) was achieved by using CC10+ and SPC+ specific adenoviruses and this was 
delivered to the mice intranasally, causing NSCLC development. (Nagaraj et. al. 2017: 
674.) Later in this thesis this model introduced above will be referred as the Kras;Lkb1 
mutant mouse model. 
 
CC10+ and SPC+ progenitors with mutant Kras (G12D oncogenic mutation) and loss of 
Lkb1 were both able to generate different lung cancer subtypes (invasive AC, AC in situ, 
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papillary AC and ASC), but it was shown that aggressive ASCs were predominantly 
initiated from CC10 positive progenitors. Acinar ACs (AAC) and pure mucinous ACs 
(MAC) were also initiated from CC10 positive cells, but not from SPC positive cells. 
(Nagaraj et al. 2017: 680–681.) 
 
The histotype-specific expression of immune related- genes was identified by a gene 
expression microarray using RNA from KL-CC10 ASC and KL-SPC AC tumors. Gene 
expression microarray results exhibited that genes functioning in immune suppression 
and chemotaxis, such as Cxcl5, Il-1b and Arg1 were more highly expressed in KL-CC10 
ASCs than in KL-SPC papillary ACs. Il-1b and Arg1 expression levels were also validated 
by quantitative real time polymerase chain reaction (qRT-PCR), while validation of the 
other immune-related genes was not performed. The study showed that ASCs 
specifically had higher expression of pro-inflammatory genes such as Il-1b and Arg1 and 
S100 calcium-protein A8 and A9. (Nagaraj et al. 2017: 673, 677–678.) 
 
3.2 Conditionally reprogrammed cells (CRC) 
 
Reproduction of adult epithelial cells demands special medium for culturing and it is 
limited by the early aging of cells, also known as senescence. It is possible to avoid this 
aging by expressing viral oncogenes in cells, but it has been shown that these modified 
cell lines can have abnormal regulatory pathways. (Liu et al. 2012: 599.) Primary human 
adult cells can also be immortalized by using exogenous human Telomerase Reverse 
Transcriptase (hTERT) and cellular genes (e.g. cdk4 gene). However, Liu et al. showed 
(2012: 599–600) that using only hTERT to immortalize breast cells led to disrupted 
differentiation in Matrigel, a commercial basement membrane matrix used for a number 
of different kind of cell culture applications (BD Biosciences 2008). 
 
Liu et al. (2012: 606), showed in the same study that epithelial cells derived from different 
tissues (tumor and normal tissue) can proliferate indefinitely using a combination of 
fibroblast feeder cells and Rho kinase inhibitor, without transferring any genetic material. 
Conditionally reprogrammed cells (CRCs) (from normal tissue) remained non-
tumorigenic and maintained a normal karyotype, unlike in the other methods described 
above. Co-cultivation of irradiated feeder cells (fibroblasts) and Rho kinase inhibitor in 
the CRC medium are the main critical factors in the process of CRC culture. (Liu et al. 
2012: 606.) Fibroblast feeder cells work as supporters to the target cells and help them 
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grow and expand by providing nutrients, growth factors and active signals (Llames – 
García-Pérez – Meana – Larcher – del Río 2015). 
 
In Verschuren group, the CRC method is being used to culture epithelial NSCLC tumor 
cells from Kras;Lkb1 mutant mouse tumors for ex vivo investigation (Nagaraj 2016). 
 
 
 Example of CRC culture. KN13B CRCs. Red arrows points to fibroblasts. The big 
cluster in the middle is a CRC colony. 10x magnification, Zeiss Axio. (Ojanen 2016). 
 
3.3 Tumor microenvironment 
 
Tumors are infiltrated and surrounded by blood vessels, stromal and immune cells, 
extracellular matrix (ECM) and other supporting structures which form human organs. 
Together these factors comprise a microenvironment of a tumor. (Betof – Dewhirst 2011: 
7.) Tumor microenvironment (TME) is identified to have a crucial role in malignant 
progression, neoplastic cell initiation and in the metastasis of tumor cells. The cell types 
which have been recognized in TME are inflammatory cells, vascular cells, fibroblasts, 
immunocytes, hematopoietic-derived cells and epithelial cells. TME isn’t just a physical 
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space, it is also a venue for different factors to interact. (Siemann 2011; Betof – Dewhirst 
2011: 7, 11.) 
 
Cancer cells and stromal cells (e.g. vascular endothelial cells, fibroblasts and immune 
cells) constitute tumors. Non-malignant (benign) stromal cells surround non-
differentiating malignant cancer cells. A major element of the cancer stroma are cancer-
associated fibroblasts (CAFs), which secrete numerous growth factors (chemokines and 
cytokines) and have a role in regulating tumor proliferation, invasion and metastasis. 
(Shiga et al. 2015: 2443, 2447.) 
 
The immune system is a critical part of the TME. Mast cells are the first cells to react to 
the tumor growth factors. Macrophages normally are the next inflammatory cells to react 
and infiltrate the growing tumor microenvironment. These tumor-associated 
macrophages (TAMs) start to secrete interleukin-1, interleukin-6, interleukin-8, tumor 
necrosis factor alpha, (TNF-α) and/or basic fibroblast growth factor (bFGF) once they are 
activated by tumor-derived transforming growth factor beta 1 (TGF- b1). TAMs are 
thought to have an essential role in signaling angiogenesis, that is necessary for tumor 
growth. Cytokines, growth factors and chemokines secreted by inflammatory cells, 
provokes epithelial proliferation and produce reactive oxygen species (ROS) that 
damage DNA, thus boosting tumor progression. (Betof – Dewhirst 2011: 10–11.) 
Neutrophils are another important immune cell type which are part of the tumor 
microenvironment (Gabrilovich – Nagaraj 2009: 20). 
 
Several types of cells and secreted proteins compose an extracellular matrix which helps 
to maintain the organization of cellular structures. The matrix is filled with proteins such 
as laminins, plasminogens, proteases, collagens, fibronectin, hyoluronan and many 
other, and this together creates an inflexible system to which cells attach. (Parker – 
Siemann 2011: 3.) Cancer cells have ability to upregulate and release proangiogenic 
factors which can induce vascular outgrowth from regular blood vessels and make 
endothelial cells unstable. In order to form a new capillary net for the tumor mass, the 
endothelial cells proliferate in the direction of the chemoattractant angiogenic factor 
source. Normal vasculature is highly organized, whereas newly constructed tumor 
neovasculature lacks organization, vessel integrity and has abnormal structure. It is 
supposed that vascular endothelial growth factor (VEGH) plays a critical role in tumor 
angiogenesis. (Parker – Siemann 2011: 3.) 
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3.4 Project specific genes of interest 
 
In this study the main focus was in the immune-related genes such as Interleukin 1b (Il-
1b), Interleukin 6 (Il-6), C-X-C motif chemokine ligand 5 (Cxcl5), C-C motif chemokine 
ligand 2 (Ccl2) and Arginase 1 (Arg1). These genes were chosen for this project since 
there have been interesting results in gene expression comparisons in a previous 
studies. In Nagaraj et al. (2017) study, Il-1b, Arg1 and Cxcl5 were identified to be 
differentially expressed between ASCs and ACs. In one study (not published yet), gene 
expression was compared by RNA sequencing between CRCs and the results showed 
that Ccl2 gene is more highly expressed in ASC CRCs compared to AC CRCs (Nagaraj 
2016). Another study identified Il-6 gene as important for Kras;Lkb1 driven lung tumors, 
making it one of the genes-of interest in this project (Koyama et al. 2016: 999). 
 
Interleukin 1b (Il-1b) is a gene that encodes protein from the interleukin 1 cytokine family. 
Activated macrophages and other cell types produces this cytokine, that has an 
important role in inflammatory responses and it is involved in numerous cellular activities 
such as cell proliferation, and differentiation and apoptosis. (Interleukin 1 beta 2017.)  
 
It has been recorded that there are at least two forms of a mammalian arginase – type 1 
and type 2 which are encoded by different genes. These isoforms differ in their 
subcellular localization, physiologic function, tissue scattering and immunologic cross 
reactivity. The type 1 form is encoded by this gene mentioned previously and it is an 
enzyme involved in urea cycle. Arginase 1 is mainly expressed in the liver and it works 
as a catalyst in a reaction where arginine hydrolyses to urea and ornithine. (Arginase 1 
2017.) Arginase 1 is commonly expressed by neutrophils which have been stimulated by 
Il-1b and other factors in the tumor microenvironment (Gabrilovich – Nagaraj 2009: 21). 
 
Chemokines have a role in activation and recruitment of a leukocytes and they are 
grouped by structure or by function. Cxcl5 gene encodes a protein which is a member of 
C-X-C motif chemokine ligand subfamily. In cancer, it is suggested that this protein is 
involved in cancer cell migration, invasion and proliferation. (C-X-C motif chemokine 
ligand 5 2017.)  
 
Interleukin 6 (Il-6) gene encodes a cytokine which is involved in maturation of B cells and 
in inflammation. It has been shown that this protein also has a capability to induce fever 
in patients with infections or autoimmune diseases. Primarily the protein is produced in 
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acute and chronic inflammation. In response to inflammation the encoded protein 
induces transcriptional inflammatory response via Il-6 receptor alpha, right after it has 
been secreted in the serum. (Interleukin 6 2017.) It has been showed that CAFs are one 
source of an Il-6 (Shiga et. al. 2015: 2443). 
  
As been mentioned previously, chemokines have a role in inflammatory processes. Ccl2 
chemokine belongs to a CC chemokine subfamily and it exhibits chemotactic activity for 
basophils and monocytes but not for eosinophils nor neutrophils. (C-C motif chemokine 
ligand 2 2017.)  
 
3.5 Hypothesis and aims of the project 
 
Based on the previous studies (Nagaraj et al. 2017), it was expected that there will be 
differences in the immune gene expression between different tumors (KL-CC10 and KL-
SPC), and also in tumor versus CRC comparison. In addition, as stromal cells are an 
important part of the tumor microenvironment, they may have an effect on tumor cell 
immune gene expression. However, there is no previous publications about stromal-cell 
conditioned media effects on CRC immune gene expression in these same experimental 
conditions so it was hard to predict the outcome. 
 
The main aims for this project were to compare gene expression between different 
tumors and CRCs and to investigate if there are any effects of stromal cell conditioned 
media to gene expression in CRCs. 
 
4 Materials and methods 
 
4.1 Cell culture 
 
Many of the cells derived from animals or plants can survive and proliferate in a favorable 
artificial environment (Alberts et al. 2012; Life technologies: 2). This environment often 
needs a suitable medium enriched with specific protein growth factors and nutrients 
(Alberts et al. 2012). Cell cultures can be derived from the tissue directly by enzymatic 
or mechanical methods or they can also be derived from cell strains or cell lines which 
have been established before (Life technologies: 2). 
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The most important requirement of a cell culture laboratory is an aseptic work area. The 
cell culture hood is the most economical and simplest way to maintain aseptic conditions 
and it decreases the risk of contamination from aerosols. (Life technologies: 7, 11.) The 
key concepts for aseptic technique is a sterile handling, good personal hygiene, sterile 
reagents and media, and sterile work area. It is crucial to keep the cells free from 
contamination by micro-organisms. Sources of biological contamination can be dirty 
work surfaces, non-sterile supplies or reagents and the airborne particles. (Life 
technologies: 11.) 
 
4.1.1 CRC culture 
 
In this project, tumors used for CRC culture were previously collected from Kras;Lkb1 
(KL)-CC10 or KL-SPC mice and cut into pieces (Table 1). One of the pieces were used 
to generate CRCs and the rest of the tumor pieces were snap frozen in liquid nitrogen 
and stored. Later, these frozen sections were used for RNA isolation (see section 4.2). 
 
Table 1. Tumor and the CRC details. 
 
CRC / Tumor ID Genotype /Cell of 
origin 
Histotype 
KN6B-T1 KL-SPC AC 
EV1093-T4 KL-SPC AC 
KN85A-T2 KL-CC10 ASC 
KN13B-T1 KL-CC10 ASC 
 
Epithelial CRCs which had been previously created in Verschuren lab from murine 
NSCLC tumors were co-cultured with murine NIH3T3 fibroblasts (ATCCÒ CRL-1658TM). 
First these NIH3T3 fibroblasts were cultured on 10 cm tissue culture dishes and 
incubated overnight at 37°C in the presence of 5% carbon dioxide (CO2). The NIH3T3 is 
a cell line established from mouse embryos (ATCC 2016). 
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 Newly thawed NIH3T3 fibroblasts with 10x magnification, Zeiss Axio (Ojanen 2016). 
 
The medium (Dulbecco's Modified Eagle Medium) which is used to culture fibroblasts 
contained 10% heat-inactivated fetal bovine serum (HI FBS), L-glutamine and antibiotics 
(penicillin/streptomycin). Before use the medium was prepared by adding components 
listed above. After incubation NIH3T3 fibroblasts were irradiated by gamma-irradiation. 
Gamma-irradiation is one of the methods used to stop the cells from proliferating (Llames 
– García-Pérez – Meana – Larcher – del Río 2015).  
 
CRCs were seeded onto irradiated NIH3T3 cells with F-12/DMEM (medium) which was 
enriched by numerous components. First 152 ml of media was removed from F12 media 
bottle. Into 348ml of F12 media (Invitrogen #11765-054) was added 116ml of DMEM with 
high glucose (Invitrogen #11965-084), 25 ml heat inactivated FBS (Gibco), 5 ml of 
PenStrep (antibiotics) and other components listed below (Table 2). For tumor versus 
CRC experiment, the cells which have been already seeded onto NIH3T3 cells were 
cultured 48 hours before used for RNA isolation (see section 4.2). 
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Table 2. Concentrations of stock solutions. 
 
Chemical Stock 
concentration 
Working 
concentration/ml 
For 500ml 
of media 
Storage 
rhEGF (from 
stock) 
0,1 mg/ml 10 ng/ml 50 µl -20°C 
Insulin (from 
stock) 
4 mg/ml 5 µg 625 µl -20°C 
Cholera toxin 
(from stock) 
0,5 mg/ml 10 ng 10 µl +4°C 
Adenine (from 
stock) 
2,4 mg/ml 24 µg/ml 5 ml -20°C 
ROCK inhibitor 
(Y-26732) (from 
stock) 
5 mg/1,5ml 
10mM 
10 µM/ml 500 µl -20°C 
Hydrocortisone 
(from stock) 
1 mg/ml 0,4 µg/ml 200 µl -20°C 
 
 
In conditioned media experiment the key was to replace the regular CRC-media with 
conditioned media from stromal cell cultures to see if there are any effect. This 
conditioned media was obtained from mouse bone marrow stromal cell (Ingo 
Ringshausen, University of Cambridge) culture. These stromal cells were first cultured 
into 10 cm plate with stromal cell media MEM Alpha + GlutaMAX (Invitrogen), with 
additional components, 10% horse serum (StemCell Technologies #06850), 10% heat 
inactivated FBS, 10uM B-mercaptoethanol (Sigma Aldrich #M6250) and 1% 
penicillin/streptomycin (Gibco #15140148). The stromal cells were cultured until they 
reached 50% confluency and afterwards a fresh F-12/DMEM media was put on the cells 
for 48 hours. This ‘conditioned’ media from the plates were collected and added to the 
CRCs for 24 hours.  
 
For the conditioned media experiments (Figure 3), all of the CRCs, generated from 
different mouse NSCLC tumors, were cultured in two 10 cm plates at the same density. 
In one plate per each CRC line, the CRC media was replaced with conditioned CRC 
media after 24 hours. Thus we had two different experimental conditions; exponentially 
growing cells in CRC-media and exponentially growing cells in conditioned media from 
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stromal cell culture. These cultures were used for RNA isolation after additional 24- hour 
culture (see section 4.2). 
 
 
 Workflow for conditioned media experiment. 
 
4.2 RNA isolation 
 
RNA isolation methods are comparable to DNA isolation methods, but it is known that 
RNA molecules are shorter and thus not so easily damaged by shearing. It means that 
the cells can be disrupted more vigorously. RNases which can be found on fingers or 
endogenously in a certain cell types, have ability to digest RNA. To avoid this digestion 
from happening, gloves and strong detergent included in the isolation medium should be 
used. (Rapley 2005: 3.)  
 
For the isolation of RNA from cells, the cells must first be lysed. As a result, there is total 
RNA, mixture of messenger RNA (mRNA), transfer RNA (tRNA), ribosomal RNA (rRNA) 
RNA 
CRC-media 
24 
hours 
48 
hours 
48 
hours 
24 
hours 
Media from 
stromal cell 
culture 
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and other forms of non-coding RNA. Only about 2% of the total RNA mixture is mRNA 
(relevant for this project). (Mulhardt 2010: 96.) 
 
First, the CRCs had to be separated from the NIH3T3 cells in the plate. To segregate 
CRCs from NIH3T3 fibroblasts, a double trypsin incubation method was a method used 
in Verschuren lab. In the first incubation trypsin detached the NIH3T3 cells allowing them 
to be discarded from the plate. During the second incubation the CRCs were detached 
from the plate by trypsin, washed with phosphate buffered saline (PBS) and freezed at -
80°C (Appendix 1). To isolate cells from snap frozen tumor pieces matching the cultured 
CRCs (section 4.1), solid tumor tissue was homogenized by using Precellys® 
homogenizer from Bertin instruments. 
 
In this project we used commercial RNA isolation kit (NucleospinÒ RNA kit) to isolate 
RNA from frozen tumor tissues and CRCs. The kit includes a lysis buffer which also 
inactivates RNases, columns used to isolate clean RNA by binding to RNA molecule and 
DNase that eliminates genomic DNA in the column (Machereney-Nagel 2016). We 
obeyed the protocol made by manufacturer, with a slight difference in the final steps, 
where we did one extra centrifugation step in order to dry the column entirely and eluted 
the RNA in 50 µl of RNase-free H2O instead of 60 µl (Machereney-Nagel 2015: 18–20). 
Quantitation of isolated RNA was performed by using spectrophotometer (NanoDrop).  
 
In order to remove DNA, it is recommended that the RNA samples are treated with 
DNase (RNase-free) before reverse transcription, especially when using Sybr Green 1 
detection as it requires that a single amplicon is produced (Sugden 2005: 337). In this 
project this step was included in RNA isolation, as the NucleospinÒ RNA kit contained 
RNase-free DNase.  
 
4.3 qRT-PCR 
 
qRT-PCR is a quantitative reverse transcription polymerase chain reaction. This method 
is used when the material to be analyzed is RNA. First total RNA or messenger RNA 
must be transcribed into a complementary DNA by a reverse transcriptase. cDNA 
generated by the reverse transcription is then used as a template for the quantitative 
PCR (qPCR). (Thermo Fisher Scientific 2015a.)  
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There are some guidelines for aseptic technique in PCR working in order to avoid 
contamination. It is important to use tips that contain a filter (aerosol barrier), to wear 
proper laboratory clothing (gloves etc.) and to decontaminate surfaces where the pre-
PCR is carried out with appropriate solution. Premixing the reagents before aliquoting 
reduces the pipetting steps and consequently reduces the chance of a contamination. It 
is suggested to perform PCR in a separate area e.g. in laminar hood with UV-light, where 
contamination measurements can be taken. The temperature cycler and area where 
post-PCR products are handled should be separated from previously mentioned area. 
(Hartley – Rashtchian 1993: S10.) 
 
A No Template Control (NTC) should be analyzed at the same time as other samples, to 
rule out any contamination caused by reagents or surfaces. NTC comprises all the 
reagents used in RT-PCR but not a RNA template, which is normally replaced with 
nuclease-free water. There should be no synthetization in NTC, however if there is any 
fluorescence, it can mean that one or more of the reagents used are contaminated. 
(Thermo Fisher Scientific 2015c.) In this project, for each primer pair on each qRT-PCR 
plate, triplicate reactions using RNase free H2O instead of the template cDNA were 
included to check for contamination of reaction reagents. 
 
4.3.1 Synthesis of complementary DNA (cDNA) 
 
Viruses have ability to generate DNA from RNA, as they contain an enzyme called re-
verse transcriptase (Mulhardt 2010: 99). Moloney murine leukemia virus reverse tran-
scriptase (MMLV-RT) and Avian myeloblastosis virus reverse transcriptase (AMV-RT) 
are generally used enzymes for the transcription (Thermo Fisher Scientific 2015a). For 
the synthesis of complementary DNA (cDNA), components needed are isolated RNA 
template, primer, buffer, RNase inhibitors, nucleotides and reverse transcriptase 
(Mulhardt 2010: 99).  
 
The synthetization of cDNA from isolated RNA were performed by using a BioRad 
thermocycler and High-Capacity cDNA Reverse Transcription Kit from Applied 
Biosystems. The kit contains MultiScribe® Reverse Transcriptase (RT), 100 mM dNTP 
Mix (nucleotides), RT Random Primers and RT Buffer (Thermo Fisher Scientific 2015b). 
Protocol we used for synthetization was High Capacity cDNA Reverse Transcription Kit 
protocol provided by Applied Biosystems. (Applied Biosystems 2010: 7–9). Before 
performing the procedure, isolated total RNA was first diluted to either 930 ng or 1000 
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ng, and the dilutions were made based on the concentrations measured by NanoDrop. 
Reverse transcription program is presented in the Table 2. After the reverse transcription, 
the cDNA was diluted using RNase-free H2O. The amount of synthetized cDNA was 
measured using the Nanodrop and the cDNA was diluted to 80ng/µl stock solutions. 
 
Table 3. Reverse transcription program on BioRad thermocycler. 
 
Step Temperature (°C) Time 
1 25°C 10 min 
2 37°C 120 min 
3 85°C 5 sec 
4 10°C  Infinity 
 
4.3.2 qRT-PCR with validated primers 
 
The design of two oligonucleotides primers is the key for sensitive and specific real-time 
assay. In gene expression measurements, primers should only anneal to distinct exons 
in order to avoid amplification of genomic DNA. (Bimal 2005: 65; Sugden 2005: 337.) 
The primers have to be complementary for the target sequence, but they can’t be self-
complementary or form dimers when binding to each other. They also have to have 
matching GC-content and have same temperature for annealing. The use of different 
softwares when designing primers have made the design and choosing reaction 
conditions simpler and less time-consuming. All necessary information, including GC-
content, product size and primer length can be input and the resources (softwares) 
provide an option of matching sequences for primers. (Bimal 2005: 65.) 
 
Primers used in Verschuren lab were designed previously based on relevant publications 
and using the NCBI PrimerBlast (Ye et al. 2012). These primers were validated prior to 
use in experiments. First, to determine if primers amplified a single, correct sized specific 
product, a terminal PCR with KAPA HiFi DNA polymerase was performed. For the 
primers which produced a single product by agarose gel electrophoresis, the efficiency 
was also assessed by generating standard curves by qRT-PCR.  
 
In this project the qRT-PCR was performed by using BioRAD CFX96 qRT-PCR machine 
and SybrGreen technology via BioRad iQTM SybrÒ Green Supermix. This preblended 
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supermix contains SybrGreen dye, iTaq™ DNA Polymerase, buffer, stabilizers for 
SybrGreen and dNTPs (BioRad 2016). The reaction involves the primers validated 
previously (reverse and forward, Table 4), SybrGreen mix and the cDNA template. If the 
cDNA template contains the gene of interest, the PCR detection system detects template 
amplification via changes in the Sybrgreen fluorescent signal. This signal is produced by 
the binding of the SybrGreen dye to double stranded DNA (dsDNA) as it is synthetized 
(Dharmaraj 2017). The fluorescence is still low in the unbound state, but upon binding to 
dsDNA the fluorescence intensifies. In the reaction there can be non-specific binding 
since SybrGreen dye will bind to any dsDNA (Nolte – Hill 2011: 1274). If a gene of interest 
is highly expressed, the cDNA template will be amplified more quickly and the Sybrgreen 
fluorescent signal will be detected at an earlier cycle in the PCR protocol (Life 
technologies 2012). The DDCT method was used to analyze the raw qRT-PCR data and 
the differences in gene expression between the samples were compared.  
 
Table 4. Reverse and forward primer details. 
 
Gene 
Name 
Forward (5’à3’) Reverse(5’à 3’) Expected 
Product 
Length (bp) 
Reference 
Il-6 CTCTGGGAAA
TCGTGGAAAT 
TCCAGTTTGGT
AGCATCCATC 
135 Primer 
BLAST 
Il-1β TGCCACCTTTT
GACAGTGATG
AGA  
CCTGGAAGGT
CCACGGGAA 
225 Verschuren 
lab stocks 
Rpl19 
(+control) 
CGGGAATCCA
AGAAGATTGA 
TTCAGCTTGTG
GATGTGCTC 
110 Verschuren 
lab stocks 
Arginase 
1  
 
TCGTGTACATT
GGCTTGCGA  
GCCAATCCCC
AGCTTGTCTA 
 Primer 
BLAST 
Ccl2 AGGTCCCTGT
CATGCTTCTG 
TCTGGACCCA
TTCCTTCTTG 
249 Lu and Kang, 
J. Biol. Chem. 
2009, 284(2): 
29087 
Cxcl5 GCATTTCTGTT
GCTGTTCACG
CTG 
CCTCCTTCTG
GTTTTTCAGTT
TAGC 
205 Duchene et 
al., J. 
Immunol 
2007, 179; 
4849-4856 
 
The desired concentrations for qRT-PCR reactions were 20 ng/µl cDNA, 300 nM forward 
primer, 300 nM reverse primer and 1X Sybgreen mix and the reaction volume was set to 
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10 µl with RNase free H2O. Each reaction was performed in triplicate, meaning that 3 
wells per reaction were used (Appendix 2). The qRT-PCR was performed in 3-step 
program with initial denaturing. This 3-step program (Table 3) comprised denaturing, 
annealing and extension phase which were repeated 40 cycles. The annealing phase 
with Arginase 1 primers was performed at 58 degrees as primer validation experiments 
identified this as the preferable temperature for Arginase 1 primers to anneal. Melt curves 
were generated by increasing the temperature by 0.5°C increments from 55°C to 95°C, 
10 second each.  
 
Table 5. qRT-PCR program. 
 
Step Temperature (°C) Time 
Initial denaturation 95°C 3 minutes 
Denaturing 95°C 10 seconds 
Annealing 60°C 15 seconds 
Extension 72°C 30 seconds 
Melt curve 55 – 95°C 10 seconds   
(0.5 degree increments) 
 
4.4 DDCT method 
 
There are different approaches for qPCR data analysis. A commonly used method is 
where concentrations of a known cDNA are used to quantify the absolute copy number 
by creating a standard curve. Another approach for data analysis is DDCT method (also 
known as Comparative CT method) which utilizes a reference gene to gain relative gene 
expression results. In this method the relative gene expression differences are calculated 
by normalizing the results against a reference gene (e.g. housekeeping gene). 
(Dharmaraj 2017.) Quantitative PCR data normalization is necessary since there can be 
variability between samples in starting material as well as in mRNA isolation, and 
differences at efficiency in reverse-transcription. Internal reference gene expression is 
quantitated in the same samples at the same PCR plate, as the target gene expression. 
Reference gene should be expressed at a constant level in the same tissue type between 
different samples. (Sugden 2005: 337.)  
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For example, in the Figure 4, average target gene Cxcl5 Cq was normalized by using 
the housekeeping reference gene Cq (Rpl19). Therefore, ΔCq = Cq target gene – Cq reference 
gene. In this case it was decided that the CRCs work as a calibrator, so ΔCq sample - 
ΔCq calibrator = ΔΔCq. Fold expression (2^(- ΔΔCq)) shows how many times more the 
sample is expressing the gene of interest. 
 
 
 Example of the DDCT method. 
 
5 Results 
 
These relative results of each experiment are merged into graphs in order to make it 
clearer. The results from different experiments are presented in different graphs and are 
not comparable between each other. In the tumor versus tumor comparison, the gene 
expression was folded over KL-SPC- tumors and in the tumor versus CRC comparison, 
the gene expression was folded over CRCs. In conditioned media experiment, the gene 
expression was folded over normal media samples.  
 
5.1 Tumor versus tumor comparison 
 
Tumors in this project were from Kras;Lkb1 mutant mouse model with either CC10+ or 
SPC+ cell-of origin (see section 3.1). Comparison were made between two different 
tumors for each cell of origin (n=2). KL-SPC tumors – namely KN6B and EV1093 displays 
orange bars in the graphs and KL-CC10 tumors (KN85A and KN13B) displays the blue 
bars in the graphs. As shown in Figure 5, there can be variety between the different 
tumors with the same cell-of origin. Therefore, the results for each tumor are exhibited 
individually instead of showing only the average for the same cell-of origin. 
 
qRT-PCR analysis showed that the expression of Il-1β mRNA was higher in KL-CC10 
tumors compared to KL-SPC tumors (Figure 5). Il-1β is an important immune gene which 
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was identified to be expressed more highly in ASC compared to AC tumors in the tumor 
gene expression microarray (Nagaraj et. al. 2017, see section 3.3). 
 
 
 Il-1β mRNA expression, fold over KL-SPCs average. 
 
Compared to the KL-SPC-tumors (Figure 6), KL-CC10 tumors were expressing Arginase 
1 mRNA at higher levels. Specially, KN85A expressed Arginase 1 expressed 17 fold 
more when comparing to the KL-SPC-tumors. Also KN13B had higher expression level 
than KL-SPC-tumors (orange bars). 
 
 
 Expression level comparison of Arginase 1 mRNA. 
 
Cxcl5 was also identified in the tumor gene expression microarray, but the difference in 
gene expression between KL-CC10 and KL-SPC tumors was not confirmed by qRT-
PCR, until now. In Figure 7, it is clear that Cxcl5 was expressed more in KL-CC10 tumors 
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compared to KL-SPC tumors, consistent with the tumor gene expression microarray 
results (see section 3.3). 
 
 
 Expression comparison of Cxcl5 gene in tumors. 
 
Figure 8 shown below, reveals that there is an opposite trend to the other genes of 
interest. Comparison of Il-6 gene expression between KL-CC10 and KL-SPC tumors 
indicates that there is no clear difference between the two tumor types. There is variation 
between individual tumors with the same cell-of origin, however, when the average of 
both tumor types is calculated, there is no difference. 
 
 
 Expression level comparison of Il-6 mRNA in tumors. 
 
Similar to Il-6, Ccl2 gene expression comparison in Figure 9 shows that there is no 
difference between KL-CC10 and the KL-SPC tumors. 
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 Expression comparison of Ccl2 gene in tumors. 
 
In tumor versus tumor comparison we have confirmed that in additional independent 
tumors the expression of Il-1β is higher in the KL-CC10 ASC tumors compared to the 
KL-SPC AC tumors. Also Arginase 1 and Cxcl5 comparison had the same trend as ll-1β 
with a big difference in gene expression levels. Il-6 had an opposite trend to the other 
genes, but it was similar to Ccl2 expression comparison which revealed that there was 
no difference between different cell-of origin tumors. 
 
5.2 Tumor versus CRCs 
 
Isolated RNA from CRCs was compared to the RNA isolated from the matching tumor 
tissue, to see if there are any differences in the expression of immune-related genes of 
interest. In all graphs the results can be compared only between CRC and its matching 
tumor (same colored bars). CRCs had lower expression of immune genes compared to 
matching tumor tissue, however there were some exceptions that will be discussed.  
 
In all tumors tested, the Il-1β expression was higher when compared to their matching 
CRCs. However, the Figure 10 shows that there is a big difference between the samples, 
which is consistent with variability in Il-1β expression shown in Figure 5. 
 
Expression of Il-1β in KN6B CRCs was not detected by qPCR at all so it was excluded 
from Figure 10. KN13B has the greatest difference in the expression of Il-1β between 
the matching tumor and the CRC according the qPCR analysis. 
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 Il-1β comparison between tumor and CRCs. 
 
Results shown in the Figure 10 were confirmed and visualized by running the qPCR 
reaction products in an agarose gel. KN6B, EV1093, KN85A and KN13B in Figure 11, 
are names of the tumors and the CRCs, whereas KL-SPC and KL-CC10 (vertically), 
stands for the genotype and cell of origin. Il-1β is visualized in the upper box and Rpl19 
in the box below. Tumor samples are placed on the left in the boxes and CRCs on the 
right.  
 
In Figure 11, we can see that for the tumor samples there is a strong Il-1β band. This 
also shows that there is very low or no Il-1β expression in CRCs compared to matching 
tumors. Rpl19 the housekeeping gene has a strong band which means that there was a 
similar amount of RNA present in the CRCs compared to the tumors. 
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 Il-1β qPCR products visualized in agarose gel. 
 
Comparison of Arginase 1 expression (Figure 12) shows that there is a very clear 
difference when comparing CRCs to the matching tumors; Arginase 1 expression is 
dramatically lower in CRCs than in the tumors. This result is similar to Il-1β expression 
comparison above, however, the Arginase 1 expression could be detected for all the 
CRCs by qRT-PCR.  
 
 
 Arginase 1 expression between tumor and CRCs. 
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For all samples there was higher expression of Cxcl5 in the tumors compared to the 
CRCs (Figure 13). The difference was quite large for KN6B, EV10903 and KN13B, 
however for KN85A the difference was less than 2 fold. 
 
 
 The Cxcl5 expression comparison between tumor and CRCs. 
 
In figure shown below (Figure 14), we can see higher Il-6 expression in the tumors 
compared to the CRCs for 3/4 samples, however the largest difference is seen for the 2 
KL-SPC tumors (KN16B and EV1093). KN85A has an opposite trend to the others, with 
twice as much Il-6 gene expression in the CRC compared to the tumor. KN13B has quite 
small difference. 
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 Il-6 expression comparison between tumor and CRCs. 
 
There is higher expression of Ccl2 in the tumors compared to the CRCs for the KL-SPC 
samples while for 1 KL-CC10, KN13B, there is no difference between the CRC and the 
tumor for this gene. Similar to Il-6, KN85A has an opposite profile to the other tumors, 
with greater than 2 fold higher Ccl2 gene expression in the CRC compared to the tumor 
tissue (Figure 15). 
 
 
 Ccl2 gene expression comparison between tumor and CRCs. 
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Generally, CRCs have lower expression of immune genes than tumors. Il-1β and 
Arginase 1 expression was dramatically lower in CRCs than in tumors. Nevertheless, 
there were a few exceptions: KN85A had higher expression of Il-6 and Ccl2 in CRCs and 
KN13B showed no difference in Ccl2 expression. 
 
5.3 Conditioned media experiment 
 
RNA from CRCs cultured in normal and stromal cell culture conditioned media was 
isolated and the gene expression of different immune genes of interest was compared in 
order to find out if there were any effect of stromal cells. Il-1β was excluded from this 
experiment since the previous experiment showed that the Il-1β gene was not expressed 
in the CRCs. 
 
There were no major differences in Arginase 1 expression with normal media when 
compared to the conditioned media (Figure 16). 
 
 
 Arginase 1 expression between normal media and conditioned media. 
 
There was no major difference in Cxcl5 gene expression between different media 
conditions (Figure 17). Cxcl5 expression is slightly increased in KN85A cells in 
conditioned media but this difference is not as large as seen for other genes of interest. 
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 Cxcl5 gene expression between normal media and conditioned media. 
 
There was no difference in the Il-6 gene expression between normal and conditioned 
media, except in KN85A, where there is almost 2-fold higher expression in Il-6 gene 
expression when CRCs are cultured with conditioned media (Figure 18). 
 
 
 Il-6 expression comparison between normal media and conditioned media. 
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KN85A with conditioned media has over 2-fold higher expression of a Ccl2 gene than 
with a normal media (Figure 19). KN13B has also a major difference, although it is 
opposite to KN85A, 2-fold decrease in the expression of Ccl2 in the conditioned media 
compared to the normal media. Also, KN6B shows a 40% decrease in the expression of 
conditioned media. In different CRCs, the conditioned media had variable effect on the 
Ccl2 expression, independent of their cell-of origin. 
 
 
 Ccl2 gene expression comparison between normal media and conditioned media. 
 
It was clear that there was no difference for ¾ cell lines (Figure 16-19), but as in tumor 
versus CRC experiment, there were exceptions. KN85A with conditioned media had 
higher expression of Ccl2 and Il-6 than with regular CRC-media (Figure 16 and 18). In 
Cxcl5 and Arginase 1 comparison there was no difference. 
 
6 Discussion 
 
In this project we used tumors and CRCs from Kras;Lkb1 mutant mouse model to 
investigate differences in immune gene expression. The three different conditions we 
had for the gene expression comparison, were tumor versus tumor, tumor versus CRC 
and CRCs with normal media versus CRCs with conditioned media from stromal cell 
culture.  
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6.1 Expression of immune-related genes in Kras;Lkb1 mutant NSCLC tumors and 
CRCs 
 
In this project we confirmed that expression of Il-1β and Arginase 1 is higher in the KL-
CC10+ tumors compared to KL-SPC+ tumors, which means that these tumor samples 
are comparable to the ones used in the microarray in Nagaraj et al (2017) study. Also 
Cxcl5 expression is higher in KL-CC10+ tumors than in KL-SPC+ tumors. This was 
expected from the microarray (Nagaraj et al. 2017) but the differential expression had 
not been confirmed before this. Other immune-related genes of interest for this project 
had different results, with Il-6 expression having an opposite trend and Ccl2 showing no 
large difference between KL-CC10 and KL-SPC tumors. 
 
As we can see in the graphs in section 5.2, CRCs generally had lower expression of 
selected genes compared to matched tumors, especially for Il-1β. When evaluating the 
raw data, we saw that in KN85A-CRC and EV1093-CRC only 1/3 replicates gave 
fluorescence (Cq >34) and in KN6B-CRC there was no fluorescence in a single well 
indicating no or very low expression of Il-1β. The reason for this may be that in tumors 
Il-1β may be expressed only by immune cells (e.g. macrophages) or that Il-1β might only 
be expressed by tumor cells in vivo, making its expression immune microenvironment 
dependent. We can also make a suggestion that Il-1β is not expressed in CRCs 
independent of cell-of origin.  
 
Also, Arginase 1 expression was dramatically lower in CRCs than in the tumors. We can 
speculate is this due the absence of Il-1β, since these two genes are both linked to the 
activity of neutrophils in cancer.  
 
So why is immune gene expression lower in CRCs? The reason for this might be found 
in the presence of immune cells in the tumor microenvironment and in the signaling 
between tumor and immune cells in vivo. As opposed to tumor tissue samples, which 
contain immune cells as well as tumor cells, there is no immune microenvironment 
present CRC epithelial cultures and no signaling between the tumor cells and immune 
cells. The results suggest that the interaction between tumor and immune cells is 
important for the expression of immune related genes, particularly to Il-1β, Arginase 1 
and Cxcl5.  
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The tumor microenvironment is composed by different cell types including stromal cells 
and this can affect expression of genes by the tumor cells. This was the main reason 
why the effect of conditioned media from stromal cell cultures on CRC expression of 
immune-related genes was investigated. 
 
Conditioned media had no effect in 3 of 4 CRCs, but increased Il-6 and Ccl2 gene 
expression in KN85A CRCs compared to normal media. This KN85A result in 
conditioned media experiment suggests that there may be a cell-line specific effect of 
conditioned media from stromal cells on immune-gene expression in Kras;Lkb1 mutant 
CRCs. This means that more experiments with more cells lines would need to be done 
to confirm this result.  
 
Results from these experiments presents the importance of the tumor immune 
microenvironment and the tumor cell-of origin for the expression of immune-related 
genes. Variation seen in the results between different tumors and between CRCs in gene 
expression is consistent with NSCLC being a complex disease. 
 
6.2 Quality control  
 
As we can see in the Table 6, I performed six different qPCR runs in total. No Template 
Controls were included on each plate for each primer set. In H2O controls there should 
not be any fluorescence as the sample used is just pure water rather than cDNA. In each 
run, there were fluorescence detected in Rpl19 (housekeeping gene) H2O controls. It 
might be that the primers used for Rpl19 master mixes has been contaminated or the 
water itself and that caused the higher Cq values. However, when evaluating the raw 
qPCR data, we saw that the Cq value for Rpl19 is normally between 17-19, so we 
concluded that the result from Rpl19 H2O controls are not relevant and that the results 
for the samples of interest could be analyzed. 
 
On the 02.12 performed qPCR run, shows that there was fluorescence in every H2O 
controls for each primer set. We checked the other results, and we saw that the Cq 
values for all primer sets in samples was lower than 30, whereas in H2O controls the Cq 
value was over 35. We therefore concluded that these values over 35 were not relevant 
to the analysis of the gene expression 
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Table 6. NTC contaminations in qPCR runs. 
 
Date Run Contaminations Cq value 
01.12 Il-6 
Il-1β 
Rpl19 
Rpl19 H2O control 3/3 wells >30 
02.12 Ccl2 
Cxcl5 
Rpl19 
Ccl2 H2O control 2/3 wells 
Cxcl5 H2O control 3/3 wells 
Rpl19 H2O control 1/3 wells 
>35 
>35 
>35 
08.12 Arginase1 
Rpl19 
Rpl19 H2O control  1/3 wells >30 
13.12 Ccl2 
Cxcl5 
Rpl19 
Ccl2 H2O control 2/3 wells 
Rpl19 H2O control 3/3 wells 
 
>40 
>30 
13.12 Il-6 
Rpl19 
Rpl19 H2O control 3/3 wells >30 
14.12 Arginase1 
Rpl19 
Rpl19 H2O control 2/3 wells >30 
 
6.3 Reliability of the results 
 
Procedures were performed by obeying the protocols and everything was written down 
in a personal lab book so that possible errors can be tracked down and procedures can 
be redone. A No Template Control reactions using RNase free H2O instead of cDNA 
template were used to identify contaminations in the qPCR experiment. A number of 
NTC wells were contaminated, however, the Cq value for these wells was significantly 
higher than the correct Cq values for the primer pairs of interest (Table 6). While it would 
have been best to repeat the qPCR plates if there was sufficient time, I believe that these 
incidents did not affect the outcome of the results. 
 
Prior to this project I did not have much experience with the procedures performed. My 
lack of experience was reflected for example in the qPCR procedure as the technical 
replicates varied from each other, meaning that there could have been pipetting errors. 
With practice I became more confident and also my pipetting skills improved. Reason for 
such a major difference (Figure 5) in gene expression could be also found in humane 
errors. After cDNA synthetization, the concentrations were measured by Nanodrop. 
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Errors in measuring could have led to a wrong calculation before dilution and therefore 
the amount of cDNA could have been greater in a certain sample. 
 
In the original plan it was envisaged that analysis of other immune-related genes would 
have been included but these had to be excluded as the primer validation was not 
successful (results not shown). The primer pairs either did not produce single specific 
product band following the terminal PCR experiment or their efficacy in a standard curve 
qPCR was not at a desired level. Also comparisons between tumors and normal lung 
were excluded because of the lack of time. For further experiments, I believe it would be 
convenient to choose larger sample size, since the sample size exhibited in this project 
(n=2 each for KL-CC10 ASC and KL-SPC AC) was relatively small to argue that the 
results are reliable representation of the immune gene expression patterns in mouse 
Kras;Lkb1 mutant NSCLC. 
 
6.4 Ethics 
 
This project obeyed good scientific practices. Working was based on the honesty, 
accuracy and diligence. All the information is shown in its entirety in this study, without 
leaving any details out. All the achievements and publications of other authors were 
respected by marking the references properly. (Finnish Advisory Board on Research 
Integrity 2014.)  
 
When it comes to animal experimentation, it is estimated that each year up to 50 million 
animals are used for research worldwide. Majority of the cases use mice and rats in the 
procedures (Flossos 2005). Verschuren lab has approval to work with mouse models 
from the Experimental Animal Committee of the University of Helsinki and the State 
Provincial Office of Southern Finland (ESAVI/9752/04.10.07/2015).  
 
The government of Finland has set an act to regulate animal experimentation; Act on the 
Protection of Animals Used for Scientific or Educational Purposes. The purpose of the 
act is to make sure that animals are used for experimentation only when it is necessary, 
and when there is no other scientifically reliable method to achieve the desired result. In 
addition, the act is intended to ensure that the experimentations cause the least possible 
amount of suffering, distress, pain or lasting harm to the animals used. Experimental 
animal establishments must have adequate and appropriate equipment, instruments and 
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facilities, including organized veterinary services. (Act on the Protection of Animals Used 
for Scientific or Educational Purposes 497/2013.) 
 
There are alternative methods to animal experimentations such as computer model 
simulations, artificial skin which has been developed for toxicity testing and also human 
volunteers are an option. It is also possible to reduce animal suffering by improving the 
experiments themselves, treating pain with medication, and by use of less invasive 
methods for experimentation. (Flossos 2005). 
 
Although there are alternative methods for animal experimentation, some of the 
experiments still require living organism. If any substitutive methods are developed, the 
law will obligate scientist to use it as it stands in the Act on the Protection of Animals 
Used for Scientific or Educational Purposes 497/2013. But until that they have no other 
choice. 
 
6.5 Future 
 
For the future it would be interesting to find out what causes the Il-1β expression in 
tumors and why the expression is higher in KL-CC10 ASCs compared to KL-SPC ACs. 
Separation of immune cells and tumor cells from fresh tumors by flow cytometry 
comparison of immune gene expression in the different cell populations is an option to 
answer this question. It may also reveal new information about tumor immune 
microenvironment and the immune related gene expression in Kras;Lkb1 mutant 
NSCLC. 
 
As discussed in section 6.2 the small sample size in this project is also a valid reason to 
repeat these experiment with extra tumors and CRCs in the future so that the results can 
be confirmed. For now, the results will work as a precursor, and they can’t be presented 
as facts. However, it is positive that the results gained from this project are in line with 
the results exhibited in Nagaraj et. al. (2017) study. 
 
I believe that I have grown professionally and improved my knowledge in this field of 
science. As been mentioned previously, I did not have much of a hands-on experience 
when I first started this project. I became familiar with the methods used in this project 
and learned to perform them independently. I am very grateful for everything I have 
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learned during this project and for the support and guiding I have received from 
Verschuren group. 
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Culture of Murine NSCLC Conditionally Reprogrammed Cells (CRC’s) 
 
Materials: sterile 
 
Irradiated NIH3T3 feeder cells 
• 10cm plate cultured in DMEM + 10% HI FBS + Pen/Strep + L-Glut 
 
CRC media: store at 4°C protected from light when not in use 
 
F12 Media (Invitrogen-11765-054)    348ml 
DMEM (Invitrogen-11965-084)    116ml 
HI FBS (Gibco-10270-106)    25ml 
Pen-strep solution (Gibco-15140-122)    5ml 
Adenine (2.4mg/ml; Sigma A2786)    5ml 
Insulin (Sigma-I2643)     625μl 
Y-27632 (Enzo Life sciences ALX-270-M0055)   500μl 
EGF (BD-354052)     50μl 
Hydrocortisone (Sigma-H4001)    200μl 
Cholera Toxin (List Biological Labs- 1000B)   10μl 
 
 
1. Adenine (Sigma A2786) 
Stock solution: 2.4 mg/ml 
Dissolve 120 mg of powder in 45 ml of 0.5N HCl on a magnetic stirrer by adding couple 
of drops of concentrated HCl. The solution becomes clear only after adding HCl. Filter 
sterilize and store 10 ml aliquots in 15 ml falcon tubes. Store at -20°C. 
 
2. Insulin (Sigma-I2643) 
Stock solution: 4 mg/ml 
Dissolve 50 mg of insulin in 2.5 ml of 0.0005N HCl by keeping it on a magnetic stirrer for 
1 hr at room temperature (solution looks turbid). Add 10 ml of sterile MQ water; now the 
solution becomes clear. Filter through 0.2 uM low protein binding filter. Aliquot in sterile 
eppendorf tubes.  
Store at -20°C. 
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(Note: Insulin dissolves when the pH of solution is around 2.5 to 3, if the solution does 
not become clear, lower the pH of the solution) 
 
3. Rho kinase inhibitor/ Y27632 (Enzo Life sciences ALX-270-M0055) 
Stock solution: 10 mM 
Dissolve 5 mg of the compound in 1.5 ml of sterile MQ water. Aliquot in sterile eppendorf 
tubes, 100-200 ul/tube.  
Store at -20°C. 
 
4. Human recombinant (hr) EGF (BD-354052) 
Stock solution: 0.1 mg/ml 
Pipet 1 ml of sterile MQ into the vial, dissolve by pipetting up and down. Aliquot in sterile 
eppendorf tubes, 250ul/tube.  
Store at -20°C for up to 3 months. 
 
5. Cholera toxin - Azide free (List Biological Labs- 1000B) 
Stock solution: 0.5 mg/ml 
Add 0.5 ml of sterile MQ water into the tube mix well by pipetting. Aliquot in sterile 
eppendorf tubes as 100 ul/tube.  
Store at 4°C. 
 
Trypsin 
 
PBS 
 
DMEM + 10% HI FBS (for inactivation of trypsin) 
 
Cell lifter (Corning-3008) 
 
Protocol: for passaging, collection of cell pellet and freezing of cell cultures 
 
1. Ensure there are sufficient plates with recently irradiated NIH3T3 feeder cells 
 
2. Ensure you had sufficient media and other reagents – warm media and trypsin in the 
water bath (37°C) 
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3. Check CRC culture plates under microscope and decide what to do 
 
4. In laminar: 
a. Remove old CRC media with vacuum and Pasteur pipette 
b. Add 3-4mL PBS to the side of the plate and tilt to cover all cells 
c. Remove PBS with vacuum and Pasteur pipette 
d. Add 1mL pre-warmed trypsin to each plate – cover all cells and incubate at 
37°C for 4-5 minutes to detach irradiated 3T3 cells 
i. During incubation time prepare 15mL tubes – if passaging and 
collecting pellet / freezing cells then prepare 2 tubes per CRC culture 
e. Check plate under microscope to see if i) 3T3 cells have detached from plate 
and ii) CRCs are still attached 
f. Remove trypsin + detached 3T3 cells with vacuum and Pasteur pipette 
g. Add 3-4mL PBS to the side of the plate and tilt to cover all cells 
h. Remove PBS with vacuum and Pasteur pipette 
i. Add 1mL pre-warmed trypsin to each plate – cover all cells and incubate at 
37°C for 4-5 minutes to detach CRCs (as much as possible) 
j. Add 5-9mL DMEM + HI FBS to each plate to inactivate trypsin 
i. Note; volume added depends on confluency of cells – more confluent 
= more media to prevent clumping 
k. Use cell lifter to gently detach any CRCs still adhered to the plate – check 
under microscope to see if all cells are in suspension 
l. Transfer cell suspension to 15mL tube(s) as necessary for passaging / 
collecting pellet / freezing pellet 
m. Centrifuge cell suspension to pellet cells: 1000rpm, 5min, RT 
i. During centrifugation: 
a. For passaging of cells; label fresh irradiated 3T3 plates with 
CRC details (ID, passage number, date) and replace 3T3 
culture medium with fresh CRC media 
b. For collection of cell pellets: label 1.5mL tubes with CRC 
details (ID, passage number, date) 
c. For freezing of cells: label 2mL cryovials with CRC details 
(ID, passage number, date) and prepare freezing solution 
(90% HI FBS + 10% DMSO) – get ice 
n. Remove media with vacuum and Pasteur pipette but do not suck up cell pellet 
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o. For passaging cells: resuspend cell pellet in fresh CRC media (1mL for each 
plate to be split) and transfer resuspended cells to 3T3 plates from step m 
(1mL per plate) à 37°C / 5% CO2 incubator 
p. For cell pellet collection: resuspend cell pellet in 1mL PBS and transfer to 
1.5mL tube from step m à centrifuge to pellet cells at 10000rpm, 1min, RT 
à remove PBS with vacuum à freeze cell pellet at -80°C 
q. For freezing of cells: resuspend cells in freezing solution (1mL for each 
cryovial to be frozen) and transfer resuspended cells to 2mL cyrovials from 
step m (1mL per cryovial) à ice à isopropanol freezing container à -80°C 
 
~70% confluent CRC’s                                  CRC colony 
 
 
Red arrows indicate irradiated flat fibroblast cells.
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Gene comparison protocol 
 
1. Dilute primers from 100uM stock to 10uM 
2. Prepare cDNA stock (80ng/µL) with nuclease-free water (see example below) 
 
  
 
3. Design how to organize the primers and samples on a 96 well plate 
a. (8 samples + 1 H2O) x 3 primer sets x 3 replicates = 81 wells 
b. total 27 + 3 error per one primer pair/gene 
c. Prepare Sybrgreen and primer master mixes – one per primer pair 
 
Reagent Concentration 1X 30X 
2X Sybrgreen 1X 5µL 150µL 
10µM Forward 
Primer 
300nM 0,3µL 9 µL 
10µM Reverse 
Primer 
300nM 0,3µL 9 µL 
Nuclease-free H20 - 1,9 µL 57 µL 
Total Volume  7,5 µL 225 µL 
 
 
 
 
 
 
 
 
 
 
cDNA	dilutions	1.12.2016
cDNA	(ng/ul) Desired	concentration	80ng/ul cDNA	required H2O	required Total
KN6B-T1 123,79 64,63 ul 35,37 100
EV1093-T4 119,31 67,05 ul 32,95 100
KN85A-T2 125,07 63,96 ul 36,04 100
KN13B-T1 122,97 65,06 ul 34,94 100
KN13B-CRC 124,15 64,44 ul 35,56 100
KN85A-CRC 122,53 65,29 ul 34,71 100
KN6B-CRC 241,75 33,09 ul 66,91 100
EV1093-CRC 143,21 55,86 ul 44,14 100
3T3-IRR 120,42 66,43 ul 33,57 100
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96-well layout 
 
 
 
 
 
 
 
4. Aliquot master mixes into assigned wells on 96 well qPCR plate – 7,5µL per well 
 
5. Aliquot 2,5µL of cDNA dilutions to assigned wells.  For H20 control wells aliquot 2,5µL 
of nuclease free H2O 
a. Add cDNA to the side of the wells avoiding the tip from touching the 
sybr/primer mastermix 
b. Change tip for each well to increase chance of accurate pipetting 
 
6. Apply coverslip and spin plate briefly (2min) at low speed (200g) to remove bubbles 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A: 1-
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         H2
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O 
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9  
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O 
H2
O 
H2
O 
C: 1-
9  
         H2
O 
H2
O 
H2
O 
D: 1-
9  
            
E: 1-
9  
            
F: 1-
9  
            
G: 1-
9  
            
H: 1-
9  
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7. Run plate – or put at 4 degrees for short time 
 
BioRAD recommended cycling protocols: 
 
3-step protocol: JD_PCR_MELTC 
 
Check reaction volume: set to 10µL 
 
Initial denaturation  95 degrees  3 minutes 
 
40 cycles: 
Denaturing   95 degrees  10 seconds 
Annealing   60 degrees  15 seconds 
(Arginase 1 58 degrees) 
Extension   72 degrees  30 seconds 
 
Melt curve   55 – 95 degrees 10 seconds  
    (0.5 degree increments) 
 
 
